FY21 Executive Medicine Application Process and Opportunities
Below is a standardized e-mail regarding the FY21 Executive Medicine application process. The Milestone (CMO, OIC, etc.) note and opportunities should be out soon.
In brief, you need to:
- Read BUMEDINST 1412.1C.
- Take a look at the FY21 opportunities. Some of the larger commands that have a CO position rotating in FY21 like NMRTC Portsmouth/San Diego/Bethesda will be on the post-command slate, not the Executive Medicine slate.
- Decide if you are interested, noting that on page 3 of the instruction it states: “Expectation is that command screened officers will be universally assignable and able to meet permanent change of station parameters.” It also states, “Rare exceptions may be considered.” In this group I’d include EFMP, dual active-duty co-location, and other similar situations. In addition, page 9 states, “Applicants who successfully screen are considered eligible for assignment to any executive medicine position within Navy Medicine…and if slated, will be assigned based on the Needs of the Navy. Officers who apply for command screening should do so with this in mind, and be willing to accept an executive medicine position for which they are slated.” If you have questions about what is possible and what is not, you need to communicate with me.
- If you have not been command screened, you must submit the required documents to PERS-4415 by 15 JUN 2020. Instructions are in the instruction. If you pass the oral and screening boards, you will have to submit a Letter of Intent, CV, bio, and list of desired positions (Executive Medicine Candidate Input form) to me by a future date TBD (because the command screening board date is TBD).
- If you have already been command screened and you are a “banked officer” with AQD 2D1 (you probably know who you are) but you ARE NOT currently serving as a CO or XO, you need to make sure your officer record is up to date as your record will be reviewed at the command screening board (see page 9 of the instruction). You DO NOT have to submit an application to PERS, though. Just make sure your record is up-to-date. After the board, you will have to submit a Letter of Intent, CV, bio, CO endorsement, and list of desired positions (Executive Medicine Candidate Input form) to me by a future date TBD (because the command screening board date is TBD).
- If you have already been command screened and you are a “banked officer” with AQD 2D1 (you probably know who you are) and you ARE currently serving as a CO or XO, you just need to submit a Letter of Intent, CV, bio, CO endorsement, and list of desired positions (Executive Medicine Candidate Input form) to me by a future date TBD (because the command screening board date is TBD).
If there are any questions, contact me. If you need guidance updating your record for the screening board, go to the Promo Prep page.
Here’s the standard e-mail…
Leaders,
Greetings. We hope that everyone is staying safe during these unprecedented times. Even so, we are still tracking the impending FY21 rotation of our Naval Medicine Leadership.
Attached are the FY21 CO/XO opportunities. To provide some clarifying information in regards to the Command Screening Notice, BUMEDNOTE 1412 will not be published this year. Rather, you can see the current notice on the Executive Medicine SharePoint Site. To locate this notice as well as the application procedure, please see current BUMEDINST 1412.1C which can be found at:
Additional information can be found on our Executive Medicine site:
https://esportal.med.navy.mil/bumed/m00/m00c/pages/executive-medicine.aspx
Packages are due NLT 15 June 2020.
For any questions, please reach out to LT Karen Maldarelli or your Deputy Corps Chief.
V/R,
CAPT Kimberly Ferland, MSC, USN
Deputy Director, Medical Service Corps
Bureau of Medicine & Surgery
Joel Schofer's Career Planning Blog 